TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Unimedic Pharma Holding AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
245
|
359
|
364 |
Financial expenses |
391
|
153
|
131 |
Earnings before taxes |
-400
|
-282
|
-178 |
EBITDA |
-49
|
-140
|
-51 |
Total assets |
7,334
|
7,301
|
7,449 |
Current assets |
31
|
281
|
114 |
Current liabilities |
545
|
682
|
1,219 |
Equity capital |
68
|
29
|
49 |
- share capital |
27
![]() |
27
|
29 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
0.9%
|
0.4%
|
0.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
-163.3%
|
-78.6%
|
-48.9% |
Return on assets (ROA) |
-0.1%
|
-1.8%
|
-0.6% |
Current ratio |
5.7%
|
41.2%
|
9.4% |
Return on equity (ROE) |
-588.2%
|
-972.4%
|
-363.3% |
Change turnover |
-115
|
25
|
87 |
Change turnover % |
-32%
|
7%
|
31% |
Chg. No. of employees |
0
![]() |
0
|
-3 |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.